Dr Russell Hull
Foothills Medical Centre and University of Calgary
Russell D. Hull, MBBS, MSc, FRCPC, FACP, FCCP, is a Professor of Medicine for the Departments of Medicine and Community Health Sciences, as well as the Director of the Thrombosis Research Unit, Calgary, Alberta, Canada.
Dr. Hull is a fellow of the Royal College of Physicians and Surgeons of Canada (RCPSC). He is a member of the Canadian Medical Association (CMA). Dr. Hull is Editor in Chief emeritus of the Journal, Clinical and Applied Thrombosis and Hemostasis (CATH). He also currently serves on the editorial boards of the American Journal of Medicine (AJM). His publications exceed 900 articles including over 390 peer reviewed articles, 66 non-peer reviewed, more than 156 book chapters and over 294 published abstracts. He is a member of editorial committee of the 2013 International Consensus Statement (ICS) for the Prevention and Treatment of Venous Thromboembolism.
Dr. Hull’s research activities involve large-scale, multi-centre clinical trials which have been responsible for improving clinical practice. His research roles include Principal Investigator of the Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III) in Calgary, the National Principal Investigator of the Randomized Trials of Long Term Treatment with Low Molecular Weight Heparin (The LITE Study), the Global Principal Investigator and Chair of the Steering Committee for the EXCLAIM Trial, which is a multicentre randomized control trial studying extended VTE prophylaxis in acutely ill medical patients with prolonged immobilization, and a Member of the Steering Committee of the global study MAGELLaN which studies rivaroxaban for preventing VTE in acutely ill medical patients. APEX, a multinational study of extended thromboprophylaxis evaluating BETRIXABAN in acutely ill medical patients has been completed. Dr. Hull is a member of the APEX executive committee.
Dr. Hull has received a number of awards and distinctions for his contributions towards improving care for patients with thrombosis including among others: the Kakkar Lectureship (2018) in recognition of the outstanding contributions for the safety of vulnerable patient population; Advances in the Management of Venous Disorders — Impact of Dr. Russell Hull’s Contributions on the Management of Thrombosis (2018) was presented by PROVOST, Loyola University, Health Sciences Division; the highest-ranking winner of the 2009-2010 CIHR/CMAJ competition for the Top Achievements in Canadian Health Research; Venous Coalition’s 2010 Venous Disease Research Award; the Honorary Membership within the European Venous Forum (2010) in recognition of his outstanding contribution to the field of venous disease; the International Union of Angiology Award (2010) in recognition of distinguished contributions to the discipline of angiology worldwide.Back to Faculty members list